NCT00502463View on ClinicalTrials.gov

Induction Chemotherapy Prior to Radio-immunotherapy in Head and Neck Cancer Stage III/IV - a Methodical Trial

NACompletedINTERVENTIONAL
Enrollment

51

Participants

Timeline

Start Date

October 3, 2007

Primary Completion Date

January 19, 2010

Study Completion Date

January 19, 2014

Conditions
Head and Neck Cancer
Interventions
DRUG

Docetaxel

75mg/m² day 1

DRUG

Cisplatin

75mg/m² day 1

DRUG

5-FU

750mg/m²/day day 1-5

RADIATION

Radiotherapy

standard fraction up to a total dose of 70Gy/35 fractions/7weeks or accelerated regimen, up to a total dose of 72Gy/42 fractions over 6 weeks

DRUG

Cetuximab

250mg/m²/week after an initial loading dose of 400mg/m²

Trial Locations (5)

1090

Medical University of Vienna, Dept. of Medicine I, Vienna

5020

UK Salzburg, LKH: Universitätsklinik für Innere Medizin III, Salzburg

6807

LKH Feldkirch, Dept. of Radiooncology, Feldkirch

8036

Medical University of Graz, Dept. of Radiooncology, Graz

8700

LKH Leoben Dept. of Hemato-Oncology, Leoben

All Listed Sponsors
collaborator

Change of sponsor 2008: new sponsor AGMT

UNKNOWN

lead

Austrian South Oncology Group

NETWORK

NCT00502463 - Induction Chemotherapy Prior to Radio-immunotherapy in Head and Neck Cancer Stage III/IV - a Methodical Trial | Biotech Hunter | Biotech Hunter